In the face of COVID-19, the U.S. failed to reliably compile even the most basic information caregivers and public
health officials required to inform an effective response. Ongoing struggles with interoperability and data standardization created a crisis that dogged the nation’s pandemic response from its earliest stages. Of the many critical lessons learned from the nation’s response to the COVID-19 pandemic, one of the most significant is this: fixing the healthcare system by enabling broad adoption of precision health must be a priority.
In just three months’ time, hc1 established a Precision Health Insight Network (PHIN) to securely ingest, organize, and normalize millions of lab test results from more than 20,000 ordering lab locations. Using multiple testing vendors with differing test compendiums for new and evolving COVID-19 viral and antibody lab tests, this PHIN powered local COVID-19 risk models that predicted and visualized hot spots around the country and served as early warning systems for local areas and ultimately powered a safe return-to-work solution.
CV19 Lab Testing Dashboard™ powered by hc1® provides hyperlocal insights into COVID-19 testing rates, positivity rates, viral and antibody testing, and risk of increasing viral activity for public health, public policy, healthcare, and laboratory decision-makers.
CV19 Lab Testing Dashboard™ powered by hc1® provides hyperlocal insights into COVID-19 testing rates, positivity rates, viral and antibody testing, and risk of increasing viral activity for public health, public policy, healthcare, and laboratory decision-makers.
Spotlight Project in the Public Health Information Sharing track
Healthcare's Most Innovating Companies of 2020
Gold for Best Team during COVID-19 Pandemic, Best Product to Combat and Reduce the Impact of COVID-19
By securely and intelligently integrating, normalizing, enriching, and transforming health data into the signals that identify risk and drive care decisions catering to each patient’s unique needs, PHINs are delivering mass personalization in healthcare.
hc1’s latest whitepaper explains how PHINs are ushering in a new era of scalable precision medicine.